Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MRVL.V Relative to the S&P 500

Seasonal Chart Analysis

Analysis of the Marvel Biosciences Corp. (TSXV:MRVL.V) seasonal charts above shows that a Buy Date of July 2 and a Sell Date of November 26 has resulted in a geometric average return of 13.62% above the benchmark rate of the S&P 500 Total Return Index over the past 6 years. This seasonal timeframe has shown positive results compared to the benchmark in 6 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 6 years by an average of 29.91% per year.

A word of caution: Only 6 years of data is available for shares of MRVL.V, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. It develops several patented and patentable chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases, and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The company was founded on August 1, 2018 and is headquartered in Calgary, Canada.

To download MRVL.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MRVL.V